Microvast Shares Surge on Renewed China Expansion Focus

Microvast Holdings Inc. shares demonstrated significant strength in pre-market trading, buoyed by the battery manufacturer’s reaffirmed 2025 financial targets and a strategic emphasis on its Chinese operations as a primary growth driver. Investor confidence in this clear strategic direction is evident, with the stock having climbed approximately 33% over the preceding four-week period.

The company’s leadership confirmed expectations for year-over-year revenue growth between 18% and 25%, alongside a projected gross margin of about 32%. A central component of this optimistic outlook is the ongoing expansion within China. At its Huzhou facility’s Phase 3.2, Microvast has allocated two gigawatt-hours of new capacity dedicated to manufacturing its flagship battery cells. This initiative is designed to enhance production efficiency and reduce per-unit costs, strengthening the company’s competitive position as it courts original equipment manufacturer (OEM) clients in the bus and specialty vehicle sectors. Full qualified production on the new line is scheduled to commence by the end of 2025.

Concurrently, Microvast is showcasing its latest battery solutions, including high-performance cells capable of achieving an 80% charge in just 15 to 20 minutes, at the BICES trade fair in Beijing. The exhibition also features high-energy batteries developed for heavy-duty applications.

Regulatory and Financial Landscape

Recent developments provided an additional positive catalyst when Microvast’s US-based plant was confirmed not to be involved in recent immigration enforcement raids, alleviating potential concerns. However, a market analyst tempered enthusiasm slightly on Thursday by downgrading their recommendation from “Strong Buy” to “Buy,” citing the stock’s recent ascent to around $4.50 per share as a reason for a potential pause in its rally.

Should investors sell immediately? Or is it worth buying Microvast Holdings?

The current positive momentum follows the company’s quarterly results released in August. While Microvast surpassed earnings per share estimates, it fell short of revenue expectations, which were set at $91.3 million. Despite this top-line miss, the company reported a positive adjusted EBITDA of $25.9 million.

Potential headwinds for the stock include an ongoing legal investigation. A law firm has initiated a probe into allegations against company executives concerning the purported loss of a government grant and potential exaggerations of its order backlog. A related class-action lawsuit is proceeding.

The critical question for investors is whether Microvast can sustain the momentum generated by its China strategy. The answer hinges on the successful launch of production at the Huzhou facility in the fourth quarter and the resolution of its legal challenges. Although the company’s technology roadmap, which includes developments in solid-state batteries, remains on track, the market will be closely monitoring these operational and legal developments.